Smartphone CBT for Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether cognitive behavioral therapy (CBT), delivered through a smartphone app, can improve symptoms of major depressive disorder (MDD). Participants will either receive the app-based therapy immediately or begin after an 8-week wait. The trial targets individuals currently diagnosed with MDD who reside in the United States and have access to a mobile smartphone with a data plan. It may suit those seeking treatment options who haven't had recent medication changes or extensive prior CBT for depression. As an unphased trial, this study provides a unique opportunity for participants to explore innovative treatment options for MDD.
Will I have to stop taking my current medications?
You can continue taking your current medications as long as you have been on a stable dose for at least 2 months before joining the study and do not change your medication during the study period.
What prior data suggests that Smartphone-delivered CBT for MDD is safe?
Research has shown that using a smartphone app for cognitive behavioral therapy (CBT) to treat major depressive disorder (MDD) is generally safe and well-tolerated. In studies where participants used this app-based therapy, no serious safety issues emerged.
One study found that users could easily navigate the app and felt comfortable with it. Another study noted that while the app's full effectiveness remains somewhat unclear, it did not cause any major adverse side effects.
Overall, the research supports the safety of smartphone-delivered CBT, with no significant safety problems identified in the studies reviewed.12345Why are researchers excited about this trial?
Smartphone-delivered CBT for Major Depressive Disorder (MDD) is unique because it brings therapy right to your pocket, offering unprecedented accessibility and flexibility. Traditional treatments for depression often involve face-to-face cognitive behavioral therapy sessions or medication like SSRIs, which can require scheduling and travel. This smartphone-based approach allows users to engage in therapy at their own pace and convenience, breaking down barriers such as transportation or time constraints. Researchers are excited about this treatment because it has the potential to reach underserved populations and provide immediate support, which could significantly improve the accessibility and effectiveness of mental health care.
What evidence suggests that Smartphone-delivered CBT is effective for major depressive disorder?
Research has shown that using a smartphone app for cognitive behavioral therapy (CBT) can effectively treat major depressive disorder (MDD). Studies have found that these apps help improve symptoms of depression. In one study, 97% of participants continued using the app, and most found it easy to use. Another study demonstrated high adherence, with people regularly using the app as intended. This trial will evaluate the effectiveness of an 8-week smartphone-delivered CBT for MDD. These findings suggest that smartphone-based CBT could effectively help people with depression feel better.34678
Who Is on the Research Team?
Sabine Wilhelm, PhD
Principal Investigator
Massachusetts General Hospital
Are You a Good Fit for This Trial?
This trial is for adults over 18 with Major Depressive Disorder (MDD) who live in the US and haven't had much CBT before. They must be stable on any current meds, not have severe substance issues, or acute suicidal thoughts. Tech literacy and owning a smartphone with data are required.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 8 weeks of Smartphone-delivered CBT for MDD
Waitlist Control
Participants are in a waitlist control group for 8 weeks before crossing over to treatment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Smartphone-delivered CBT for MDD
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor
Koa Health B.V.
Industry Sponsor